Latest Impairments News

Page 20 of 98
Green360 Technologies has moved its MKX metakaolin product from testing into commercial supply, securing a binding agreement with Holcim Australia while cutting annualised fixed cash costs by about $1.6 million. The progress comes against a $4.25 million FY2026 loss, $3.93 million in operating cash outflows and an explicit need to prove the business can scale before its cash buffer runs down.
Victor Sage
Victor Sage
29 Sept 2026
SciDev Limited (ASX:SDV) finished FY26 with a sharp annual earnings decline, but a leaner business and stronger second-half performance offer a potential reset. Revenue fell 17% and underlying EBITDA dropped 49%, while the company exited loss-making international operations and rebuilt net cash to $6.8 million.
Victor Sage
Victor Sage
29 Sept 2026
Strike Energy is moving from construction into execution, with its 85 MW South Erregulla power project nearing commercial operations and a 251 PJ West Erregulla reserve base underpinning its next gas development. The opportunity comes with a weaker FY26 earnings result, A$111.4 million of net debt and major funding obligations arriving from late 2026.
Maxwell Dee
Maxwell Dee
29 Sept 2026
Sea Forest has reported a sharp lift in SeaFeed revenue during its first full year as an ASX-listed company, but remains loss-making as it funds production and market expansion. The methane-reduction specialist ended FY26 with $27.8 million in cash and term deposits and no borrowings.
Victor Sage
Victor Sage
29 Sept 2026
Besra Gold’s FY2026 report puts its Gold Purchase Agreement with major shareholder Quantum Metal Recovery at the centre of the company’s financial risk profile. Funding received under the deal has been recorded as a contract liability tied to potential future gold deliveries, while the report also discloses an AU$140,000 payment to a former director.
Maxwell Dee
Maxwell Dee
29 Sept 2026
Heartland Group Holdings (NZX: HGH, ASX: HGH) more than doubled FY2026 net profit as margins widened, asset quality improved and its proposed TSB merger moved towards a shareholder vote. The bank also reported a 16% fall in restated emissions, though much of its climate-risk work remains incomplete or estimate-driven.
Victor Sage
Victor Sage
29 Sept 2026
Global X Hydrogen ETF reported a $33.5 million profit for the year to 30 June 2026, driven almost entirely by fair-value gains. But the ASX-listed fund has since seen its net asset value fall by more than 10% as hydrogen-related holdings weakened.
Victor Sage
Victor Sage
28 Sept 2026
Patrys has moved its injectable quetiapine program into human testing, while its FY2026 annual report warns the company will need further funding within 12 months. The company ended the year with $3.36 million in cash after raising capital and acquiring the RLS-2202 development program.
Victor Sage
Victor Sage
28 Sept 2026
Cynata Therapeutics (ASX:CYP) has reported a $9.25 million loss, negative net assets and a material uncertainty over going concern after its two major clinical trials failed to demonstrate efficacy. The company has since cut its workforce to zero, shifted management to the board and secured a $600,000 R&D tax incentive loan while it considers the future of its Cymerus platform.
Ada Torres
Ada Torres
28 Sept 2026
Western Ridge Resources reported a $12.22 million loss for the year ended 30 June 2026, with cash falling to $407,860 and its auditor warning of a material uncertainty over the company’s ability to continue as a going concern. The company is now relying on Keystone drilling and further funding to advance its Nevada exploration strategy.
Maxwell Dee
Maxwell Dee
28 Sept 2026
ActivEX has eliminated its borrowings and reported a 310,000-ounce gold resource at Mt Hogan, but the balance sheet remains dependent on future funding. The ASX-listed explorer posted a $2.149 million loss after impairing exploration assets by $2.616 million.
Maxwell Dee
Maxwell Dee
28 Sept 2026
Metrics Master Income Trust has been suspended from trading after warning that its audited FY2026 financial report may differ materially from unaudited figures released last month. The final report is expected on 30 September, but the trust has not disclosed the nature or size of the revisions.
Claire Turing
Claire Turing
28 Sept 2026

Browse the archive

Full archive